Ruth A. Roberts, PhD, ERT, FBTS, ATS, FRSB, FRCPath

Director and Cofounder
ApconiX
Macclesfield, England, United Kingdom

Presentation(s):

• Seizure Liability: New Approaches to Detection (S04)

  Monday, November 18, 2024
  2:00 PM - 5:00 PM CT

• An Integrated Approach for Early In Vitro Seizure Prediction Utilizing Human Derived Induced Pluripotent Stem Cells and Human Ion Channel Assays (S04-5)

  Monday, November 18, 2024
  4:10 PM - 4:35 PM CT

• Benefits of Early In Vitro Screening for Seizure Liability in Problem Solving and Decision Making (P407)

  Monday, November 18, 2024
  5:00 PM - 6:30 PM CT

• T2-MRI Mapping and Fluidic Neurofilament Light (NfL) as a Minimally Invasive Correlate of Central Nervous System (CNS) Toxicity in a Cuprizone Model: A Biomarker Study (P121)

  Monday, November 18, 2024
  5:00 PM - 6:30 PM CT

• Targeted Protein Degrader Therapeutics: Opportunities and Challenges (S16)

  Wednesday, November 20, 2024
  9:00 AM - 12:00 PM CT